Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(771/week)
Manufacturing
(403/week)
Energy
(326/week)
Technology
(754/week)
Other Manufacturing
(264/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Prion
Jun 01, 2020
Proteostasis Therapeutics Announces In Vitro Data for PTI-129 as Potential Treatment Candidate for COVID-19
Oct 08, 2019
ProMIS Neurosciences Identifies Novel Antibody Candidates for Multiple System Atrophy
Aug 27, 2019
ProMIS Neurosciences Appoints Internationally Recognized Researcher in Alzheimer's Disease in Down Syndrome Dr. Andre Strydom to its Scientific Advisory Board
Jun 19, 2019
ProMIS Neurosciences Appoints Renowned Parkinson's Disease Expert Dr. C. Warren Olanow to Scientific Advisory Board
Jun 10, 2019
Is Infection The Missing Link For Alzheimer's Disease?
May 28, 2019
ProMIS Neurosciences Identifies Novel Antibodies for Alzheimer's Disease with Selectivity for the Neurotoxic Form of Tau
Dec 17, 2018
ProMIS Neurosciences Appoints Renowned Neuroscientist, Dr. Rudolph Tanzi, to Scientific Advisory Board
Nov 12, 2018
Brain Research Foundation To Honor Frederick A. Gibbs Discovery Award Recipients
Oct 25, 2018
Mercaptor Announces the Appointment of World-Renowned Neuropathologist, Dr. Adriano Aguzzi to Scientific Advisory Board
Jun 26, 2018
ProMIS Neurosciences Unique Discovery Platform Generates Potential New Antibody Therapeutics for Neurodegenerative Diseases
Apr 26, 2018
TSO3 Details Results of Prion Inactivation Studies
Mar 20, 2018
ProMIS Neurosciences Appoints Dr. Sharon Cohen to Scientific Advisory Board
Mar 14, 2018
Reports indicate brain surgeons are at risk for transmitted Alzheimer's disease, says Dr. Leslie Norins on ALZgerm.org
Nov 13, 2017
ProMIS Neurosciences Announces Third Quarter 2017 Results
Sep 19, 2017
ProMIS Neurosciences Announces Successful Humanization of Lead Product Candidate PMN310 for Alzheimer's Disease
Sep 13, 2017
ProMIS Neurosciences Designates PMN330 as Third, Validated Lead Product for Development in Alzheimer's Disease
Aug 29, 2017
New Antibodies Target Structures Shared by Proteins Thought to Worsen Several Neurological Diseases
Aug 11, 2017
ProMIS Neurosciences Announces Second Quarter 2017 Results
Jun 06, 2017
ProMIS(TM) Neurosciences Appoints William C. Mobley to Scientific Advisory Board
Latest News
Jul 9, 2025
California American Water Announces $25,000 Grant to support City of San Marino Fire Department
Jul 9, 2025
Alliant Energy Corporation Announces Second Quarter Earnings Release and Conference Call
Jul 9, 2025
HNI Corporation Second Quarter Fiscal 2025 Results Conference Call
Jul 9, 2025
Pembina Pipeline Corporation Declares Quarterly Preferred Share Dividends and Announces Second Quarter 2025...
Jul 9, 2025
Novanta Inc. Schedules Earnings Release and Conference Call for Tuesday, August 5, 2025
Jul 9, 2025
Astronics Corporation Augments FAA Certification Services with Acquisition of Envoy Aerospace
Jul 9, 2025
Vertical Aerospace Announces Launch of Proposed Underwritten Public Offering
Jul 9, 2025
Acuren Corporation Announces Upcoming Participation in the CJS Securities 25th Annual “New Ideas” Summer...
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events